| PERIOD ENDING | 3-Apr-09 | 9-Feb-09 | 3-Oct-08 | 4-Jul-08 | | Total Revenue | 4,111,700 | 3,952,400 | 4,238,700 | 4,437,100 | | Cost of Revenue | 3,169,300 | 3,083,400 | 3,406,700 | 3,601,300 | | | Gross Profit | 942,400 | 869,000 | 832,000 | 835,800 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 258,800 | 261,200 | 285,300 | 277,500 | | Non Recurring | 18,900 |
-
|
-
|
-
| | Others | 274,000 | 282,200 | 312,100 | 317,200 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 390,700 | 325,600 | 234,600 | 241,100 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 8,900 | 3,200 | 9,300 | (3,800) | | Earnings Before Interest And Taxes | 399,600 | 328,800 | 243,900 | 237,300 | | Interest Expense | 69,100 | 68,700 | 58,800 | 63,900 | | Income Before Tax | 330,500 | 260,100 | 185,100 | 173,400 | | Income Tax Expense | (51,800) | 99,500 | (266,600) | 52,800 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 382,300 | 160,600 | 451,700 | 120,600 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 382,300 | 160,600 | 451,700 | 120,600 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $382,300 | $160,600 | $451,700 | $120,600 |
|
2.27% Nasdaq 
Income Statement
